• Viridian Therapeutics (NASDAQ:VRDN) Earns Buy Rating from Needham & Company LLC

    المصدر: Buzz FX / 07 يناير 2025 07:26:15   America/Chicago


    Viridian Therapeutics (NASDAQ:VRDN) Earns Buy Rating from Needham & Company LLC Written by MarketBeat January 7, 2025 Share Link copied to clipboard. Viridian Therapeutics ( NASDAQ:VRDN - Get Free Report ) 's stock had its "buy" rating reis
    Read more...
شارك على،